Friday, 13 October 2017

Blood Culture Tests become Quicker and More Accurate with Automated Techniques

Generally, blood does not contain any kind of bacteria or fungi. A blood culture test detects existence of bacteria, fungi, or microbiological infection in the blood. It is useful for treating several bacterial infections that spread into the blood in several circumstances such as osteomyelitis, meningitis, pneumonia, kidney infection, and sepsis.


Conventional Techniques Vs Automated Technologies

Standard blood culture bottles comprise one holding aerobic culture media and the other containing anaerobic media. Usually at least 10-15 mL of blood specimen should be collected using venepuncture and injected into blood culture bottles. For maximizing diagnostic yields of blood cultures, multiple sets of cultures may be taken by healthcare specialists. 

BioMérieux is a world leader in microbiology and considered to be a major player in in vitro diagnostics. The company has developed BacT/ALERT VIRTUO, which is a completely automatic blood culture system. It is easy to use and operates with load-and-go technology. The uploading of bottles is fully automated with visual and addible alarms. It offers powerful exclusive algorithms, high thermal stability, and superior optics, which increase performance and translate into faster detection of bloodstream infections.

Market Overview

According to Grand View Research, Inc., increasing frequency of bloodstream infections and infectious diseases is the most important aspect predicted to propel growth of the blood culture test market over the forecast period. The market value is estimated to reach USD 6.6 billion by 2025. Demand for advanced techniques to diagnose infectious diseases and conditions like sepsis is another key driving factor. Automated blood culture systems are predicted to form the fastest growing segment due to the accuracy and efficiency they offer. Reference laboratories are anticipated to grow rapidly due to outsourcing of blood tests by hospitals. 

With well-developed infrastructure, North America is the leading regional market and accounted for the largest market share in 2016. Asia Pacific is estimated to grow at the highest CAGR during the forecast period due to high incidence of infectious diseases and presence of refining healthcare and R&D infrastructures. 

Some of the major players operating in the blood culture test market are Becton, Dickinson and Company; Thermo Fisher Scientific, Inc.; bioMérieux SA; Danaher Corporation; Roche Diagnostics; and Bruker Corporation.

To get free sample request at:

No comments:

Post a Comment